Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yang Mao

Showing results (61-70 of 288) with videos related to

Pageof 29
Sort By:
Frontiers in Neurology|February 8, 2018
Emerging Understanding of the Mechanism of Action for Dimethyl Fumarate in the Treatment of Multiple SclerosisElizabeth A Mills, Magdalena A Ogrodnik, Andrew Plave, et al.
Lung Cancer (Amsterdam, Netherlands)|October 22, 2003
Histology-related variation in the treatment and survival of patients with lung carcinoma in CanadaLin Xie, Anne-Marie Ugnat, Judy Morriss, et al.
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|February 11, 2004
Environmental tobacco smoke and the risk of pancreatic cancer: findings from a Canadian population-based case-control studyPaul J Villeneuve, Kenneth C Johnson, Yang Mao, et al.
International Journal of Epidemiology|March 27, 2002
Brain cancer and occupational exposure to magnetic fields among men: results from a Canadian population-based case-control studyPaul J Villeneuve, David A Agnew, Kenneth C Johnson, et al.
American Journal of Translational Research|June 18, 2014
IFN-β alters neurotrophic factor expression in T cells isolated from multiple sclerosis patients - implication of novel neurotensin/NTSR1 pathway in neuroprotectionJohn Soltys, Julia Knight, Eugene Scharf, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 11, 2018
Impact of trial design and patient heterogeneity on the identification of clinically effective therapies for progressive MSElizabeth A Mills, Joel A Begay, Caitlyn Fisher, et al.
Scientific Reports|July 1, 2016
Iron overload by Superparamagnetic Iron Oxide Nanoparticles is a High Risk Factor in Cirrhosis by a Systems Toxicology AssessmentYushuang Wei, Mengzhu Zhao, Fang Yang, et al.
Scientific Reports|November 21, 2019
Author Correction: Bidirectional regulatory potentials of short-chain fatty acids and their G-protein-coupled receptors in autoimmune neuroinflammationJeongho Park, Qin Wang, Qi Wu, et al.
Scientific Reports|June 22, 2019
Bidirectional regulatory potentials of short-chain fatty acids and their G-protein-coupled receptors in autoimmune neuroinflammationJeongho Park, Qin Wang, Qi Wu, et al.
Frontiers in Neurology|August 20, 2025
JCV-specific cell-based assays for PML risk assessment in lupus and multiple sclerosis patients with and without natalizumabQi Wu, Elizabeth A Mills, Qin Wang, et al.
Pageof 29

Showing results (61-70 of 288) with videos related to

Sort By:
Pageof 29
Frontiers in Neurology|February 8, 2018
Emerging Understanding of the Mechanism of Action for Dimethyl Fumarate in the Treatment of Multiple SclerosisElizabeth A Mills, Magdalena A Ogrodnik, Andrew Plave, et al.
Lung Cancer (Amsterdam, Netherlands)|October 22, 2003
Histology-related variation in the treatment and survival of patients with lung carcinoma in CanadaLin Xie, Anne-Marie Ugnat, Judy Morriss, et al.
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|February 11, 2004
Environmental tobacco smoke and the risk of pancreatic cancer: findings from a Canadian population-based case-control studyPaul J Villeneuve, Kenneth C Johnson, Yang Mao, et al.
International Journal of Epidemiology|March 27, 2002
Brain cancer and occupational exposure to magnetic fields among men: results from a Canadian population-based case-control studyPaul J Villeneuve, David A Agnew, Kenneth C Johnson, et al.
American Journal of Translational Research|June 18, 2014
IFN-β alters neurotrophic factor expression in T cells isolated from multiple sclerosis patients - implication of novel neurotensin/NTSR1 pathway in neuroprotectionJohn Soltys, Julia Knight, Eugene Scharf, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 11, 2018
Impact of trial design and patient heterogeneity on the identification of clinically effective therapies for progressive MSElizabeth A Mills, Joel A Begay, Caitlyn Fisher, et al.
Scientific Reports|July 1, 2016
Iron overload by Superparamagnetic Iron Oxide Nanoparticles is a High Risk Factor in Cirrhosis by a Systems Toxicology AssessmentYushuang Wei, Mengzhu Zhao, Fang Yang, et al.
Scientific Reports|November 21, 2019
Author Correction: Bidirectional regulatory potentials of short-chain fatty acids and their G-protein-coupled receptors in autoimmune neuroinflammationJeongho Park, Qin Wang, Qi Wu, et al.
Scientific Reports|June 22, 2019
Bidirectional regulatory potentials of short-chain fatty acids and their G-protein-coupled receptors in autoimmune neuroinflammationJeongho Park, Qin Wang, Qi Wu, et al.
Frontiers in Neurology|August 20, 2025
JCV-specific cell-based assays for PML risk assessment in lupus and multiple sclerosis patients with and without natalizumabQi Wu, Elizabeth A Mills, Qin Wang, et al.
Pageof 29